Back to Search
Start Over
Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma
- Authors :
- UMC Utrecht
MS Medische Oncologie
Cancer
Gluck, W. Larry
Gounder, Mrinal M.
Frank, Richard
Eskens, Ferry
Blay, Jean Yves
Cassier, Philippe A.
Soria, Jean Charles
Chawla, Sant
de Weger, Vincent
Wagner, Andrew J.
Siegel, David
De Vos, Filip
Rasmussen, Erik
Henary, Haby A.
UMC Utrecht
MS Medische Oncologie
Cancer
Gluck, W. Larry
Gounder, Mrinal M.
Frank, Richard
Eskens, Ferry
Blay, Jean Yves
Cassier, Philippe A.
Soria, Jean Charles
Chawla, Sant
de Weger, Vincent
Wagner, Andrew J.
Siegel, David
De Vos, Filip
Rasmussen, Erik
Henary, Haby A.
- Publication Year :
- 2020
Details
- Database :
- OAIster
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1395300312
- Document Type :
- Electronic Resource